| Online-Ressource |
Verfasst von: | Zwicker, Felix [VerfasserIn]  |
| Hoefel, Sebastian [VerfasserIn]  |
| Kirchner, Corinna [VerfasserIn]  |
| Huber, Peter E. [VerfasserIn]  |
| Debus, Jürgen [VerfasserIn]  |
| Schempp, Michael [VerfasserIn]  |
Titel: | Hypofractionated radiotherapy with simultaneous-integrated boost after breast-conserving surgery compared to standard boost-applications using helical tomotherapy with TomoEdge |
Verf.angabe: | Felix Zwicker, Sebastian Hoefel, Corinna Kirchner, Peter E. Huber, Juergen Debus and Michael Schempp |
E-Jahr: | 2021 |
Jahr: | April 3, 2021 |
Umfang: | 12 S. |
Teil: | volume:41 |
| year:2021 |
| number:4 |
| pages:1909-1920 |
| extent:12 |
Fussnoten: | Gesehen am 17.05.2021 |
Titel Quelle: | Enthalten in: Anticancer research |
Ort Quelle: | Attiki, 2004 |
Jahr Quelle: | 2021 |
Band/Heft Quelle: | 41(2021), 4, Seite 1909-1920 |
ISSN Quelle: | 1791-7530 |
Abstract: | Background/Aim: This comparative plan study examines a range of boost-radiation methods in adjuvant radiotherapy of breast cancer using helical intensity-modulated radiotherapy with TomoEdge-technique. Impact of hypofractionated radiation with simultaneous-integrated boost (SIB) and influence of differing assumed α/β-values were examined. Patients and Methods: For 10 patients with left-sided breast cancer each four helical IMRT-plans with TomoEdge-technique were created: hypofractionated+SIB (H-SIB) (42.4/54.4 Gy, 16 fractions), normofractionated+SIB (N-SIB) (50.4/64.4 Gy, 28 fractions), hypofractionated+sequential-boost (H-SB) (42.4 Gy/16 fractions+16 Gy/8 fractions), normofractionated+ sequential-boost (N-SB) (50.4 Gy/28 fractions+16 Gy/8 fractions). Equivalent doses (EQD2) to organs-at-risk (OAR) and irradiated mammary-gland were analysed for different assumed α/β-values. Results: The mean EQD2 to OAR was significantly lower using hypofractionated radiation-techniques. H-SIB and H-SB were not significantly different. H-SIB and N-SIB conformed significantly better to the breast planning-target volume (PTV) and boost-volume (BV) than H-SB and N-SB. Regarding BV, mean EQD2 was significantly higher for all α/β-values investigated when using H-SIB and N-SIB. Regarding PTV, there were no clinically relevant differences. Conclusion: Relating to dosimetry, H-SIB is effective compared to standard-boost-techniques. |
DOI: | doi:10.21873/anticanres.14957 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.21873/anticanres.14957 |
| Volltext: https://ar.iiarjournals.org/content/41/4/1909 |
| DOI: https://doi.org/10.21873/anticanres.14957 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | breast cancer |
| helical tomotherapy |
| Hypofractionated radiotherapy |
| IMRT |
| SIB |
| simultaneous integrated boost |
| TomoEdge |
K10plus-PPN: | 1757941452 |
Verknüpfungen: | → Zeitschrift |
Hypofractionated radiotherapy with simultaneous-integrated boost after breast-conserving surgery compared to standard boost-applications using helical tomotherapy with TomoEdge / Zwicker, Felix [VerfasserIn]; April 3, 2021 (Online-Ressource)